Peter D. Noymer
Nessuna posizione attualmente
Profilo
Peter D.
Noymer worked as the President, Chief Executive Officer & Director at Kedalion Therapeutics, Inc. He was also the Director-Systems Engineering at Aradigm Corp.
and the Vice President-Product Research & Development at Alexza Pharmaceuticals, Inc. He was a Professor at Carnegie Mellon University.
He served as the CTO, Executive VP-Research & Development at SteadyMed Therapeutics, Inc. and as the Chief Operating Officer & Executive Vice President at SteadyMed Ltd.
Noymer holds a graduate and doctorate degree from Massachusetts Institute of Technology and an undergraduate degree from Princeton University.
Precedenti posizioni note di Peter D. Noymer
| Società | Posizione | Fine |
|---|---|---|
Kedalion Therapeutics, Inc.
 Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | Amministratore Delegato | 09/10/2019 |
| STEADYMED LTD | Direttore operativo | 10/11/2017 |
SteadyMed Therapeutics, Inc.
 SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Steadymed Therapeutics, Inc. develops drug delivery therapeutics devices. The company was founded by Amir Genosar, Ian Solomon and Gideon Kahana in 2005 and is headquartered in San Ramon, CA. | Direttore Tecnico/Scientifico/R&S | 01/01/2017 |
| ARADIGM CORPORATION | Corporate Officer/Principal | 01/07/2006 |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | Corporate Officer/Principal | - |
Formazione di Peter D. Noymer
| Massachusetts Institute of Technology | Doctorate Degree |
| Princeton University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Alexza Pharmaceuticals, Inc.
 Alexza Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexza Pharmaceuticals, Inc. is a pharmaceutical company. It focused on the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. Its product candidates are AZ-002 and AZ-007. The company was founded by Alejandro C. Zaffaroni in 2000 and is headquartered in Mountain View, CA. | Health Technology |
Aradigm Corp.
 Aradigm Corp. Pharmaceuticals: MajorHealth Technology Aradigm Corp. was a pharmaceutical company, which was focused on the development and commercialization of drugs delivered by inhalation for the prevention and treatment of severe respiratory diseases by pulmonologists. The company was founded in 1991 and was headquartered in Hayward, CA. | Health Technology |
SteadyMed Therapeutics, Inc.
SteadyMed Therapeutics, Inc. Medical/Nursing ServicesHealth Services Steadymed Therapeutics, Inc. develops drug delivery therapeutics devices. The company was founded by Amir Genosar, Ian Solomon and Gideon Kahana in 2005 and is headquartered in San Ramon, CA. | Health Services |
SteadyMed Ltd.
 SteadyMed Ltd. Pharmaceuticals: MajorHealth Technology SteadyMed Ltd. was engaged in the research, development, and manufacture of pharmaceutical products through the PatchPump technology. Its portfolio included Trevyent for pulmonary arterial hypertension and At Home Patient Analgesia for post-surgical pains. The company was founded on June 15, 2005 and was headquartered in Rehovot, Israel. | Health Technology |
Kedalion Therapeutics, Inc.
Kedalion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Kedalion Therapeutics, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of topical ophthalmology therapies based on its proprietary AcuStream platform. The company was founded by Mark Blumenkranz and Ehud Ivri and is headquartered in Menlo Park, CA. | Health Technology |
- Borsa valori
- Insiders
- Peter D. Noymer
